Processed meat is linked to diabetes, colorectal cancer. Is deli meat also unhealthy? 10 brands you can buy in Canada, ranked by a nutrition coach
Health Canada has classified deli meats as highly processed foods, and for good reason. Many varieties are packed with salt and preservatives, which have been linked to increased risks of ailments like heart disease, type 2 diabetes and colorectal cancer. And now, a new study reviewing research continues to indicate how harmful processed meat can be for your health.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle.
What does the study say?
According to the study, published on June 30 in the Nature Medicine journal, researchers analyzed dozens of prior studies that looked at how consuming processed meat is linked to an increased risk of heart disease, type 2 diabetes and colorectal cancer. Research showed regularly consuming processed meat had a link to an increased risk of coronary heart disease. However, this was statistically insignificant and could've occurred by chance.
But comparing a diet of 50 g of processed meat per day versus none showed an increased risk of type 2 diabetes and colorectal cancer. This amount of processed meat equates to about two or three slices of packaged deli meat, depending on the brand. Eating this amount daily compared to none led to, on average:
Type 2 diabetes: A 30 per cent rise in risk of developing type 2 diabetes.
Colorectal cancer: A 26 per cent rise in risk of developing colorectal cancer.
According to the Globe and Mail, researchers also offered a conservative estimate. Compared to eating no processed meat, consuming between 0.6 to 57 g of processed meat per day came with — on average — at least a seven per cent higher risk of colorectal cancer and an 11 per cent higher risk of type 2 diabetes. As consumption rose, so did the risk of these health conditions.
As a nutrition coach, I know consistently eating balanced meals sometimes means choosing convenience. Deli meats are a super quick source of protein that can help people create more nutritious meals when they're short on time. Here, I've ranked 10 of the most common deli meats found in Canadian grocery stores — like turkey breast, ham, roast beef and Canadian-style bacon — using nutritional breakdowns and official health recommendations to give you a clear picture of what you can safely add to your cart and what might be worth rethinking.
Do I have to stop eating deli meats entirely?
While processed meat has been under scrutiny for years, that doesn't mean you have to cut out deli meats completely. You can enjoy them occasionally as part of a balanced diet, especially if you choose leaner, lower-sodium options. The key is to read labels carefully and prioritize minimally processed sources of protein whenever possible. You should also keep an eye on portion sizes to limit your overall exposure to high sodium and fat in processed meats.
What to look for when buying deli meat
Claims you see on the front of deli meat packaging like "natural," "nitrate-free" or "artisan" aren't regulated in Canada. Instead, check the Nutrition Facts table and ingredients list. Here's what to aim for:
Protein: At least 8 to 10 g per 56 g serving
Sodium: Preferably under 500 mg per serving (Canada's recommended sodium limit is 2,300 mg/day)
Fat: Lean options will have 2 g or less per serving
Ingredient list: Shorter is better. Look for real cuts of meat ("turkey breast" or "top round") over vague blends ("mechanically separated meats").
How I ranked these meats
To create this list, I started with Canada's most common and popular deli-style meats — turkey, chicken, ham and roast beef — and added a few popular extras like prosciutto, back bacon and Montreal smoked meat. Each meat was ranked using:
Nutrition per 56 g serving: Protein, fat and sodium
Processing level: Is it oven-roasted, cured, smoked or ultra-processed?
Health guidelines: from Health Canada, Heart & Stroke Foundation and the Canadian Cancer Society
Health Canada recommended limiting highly processed foods and keeping sodium intake under 2,300 mg per day. The Canadian Cancer Society also advised eating no more than three servings of red or processed meat per week. These guidelines shaped the cutoff points I used in this ranking.
1. Schneider's Deli Best Oven-Roasted Turkey Breast
Per 56 g (about two slices):
Calories: 56
Protein: 12 g
Fat: 0.3 g (Saturated: 0.06 g)
Sodium: 431 mg
Carbohydrates: 1.1 g
Turkey is a popular protein (Canadians spent about $466 million on turkey in 2024). It's lean, relatively low in fat and delivers a decent protein hit per serving. The ultra-lean turkey option from Schneider's is low in fat and sugar, high in protein and made with straightforward ingredients. Its sodium is moderate compared to most deli options. For health-conscious shoppers, this is a consistent front-runner.
2. Olymel Original Cooked Chicken Breast
Per 56 g (about three slices):
Calories: 56
Protein: 9 g
Fat: 1.4 g (Saturated: 0.35 g)
Sodium: 438 mg
Carbohydrates: 0.9 g
Chicken is the most popular meat in Canada by a landslide, but hasn't been a top choice as a deli meat until more recently. Chicken is a great deli option since it's more nutritionally balanced than other cuts. Olymel's version is nitrite-free, sans preservatives and contains solid lean protein, minimal fat and moderate sodium. It's a reliable choice if you want to avoid preservatives, and its flavour is neutral enough to include in sandwiches or wraps.
3. Maple Leaf Natural Selections Shaved Slow Roasted Beef
Per 56 g (about eight to nine slices):
Calories: 58
Protein: 12 g
Fat: 1.1 g (Saturated: 0.6 g)
Sodium: 464 mg
Carbohydrates: 1.1 g
Red meat has a bad rap, and while it's best to limit your overall intake, lean cuts will give you a hefty serving of protein with minimal fat, plus iron and vitamin B12. A grocery store staple, Maple Leaf's Natural Selections Roast Beef, is gluten- and nitrite-free, made from natural ingredients and has a clean, lean protein profile. With about 12 grams of protein and just over 1 gram of fat per serving, it'll help keep you full with moderate sodium.
4. Olymel Smart & Natural Black Forest Smoked Ham
Per 56 g (about four slices):
Calories: 56
Protein: 11g
Fat: 2g (Saturated: 0.6g)
Sodium: 481mg
Carbohydrates: 0g
Pork-based deli meats like ham and salami are the most popular type in Canada, but they can also be higher in fat and sodium. One exception is lean ham, including Olymel's smoked black forest version, which is nitrite-free, gluten-free and made with natural ingredients. At just 2 g of fat and 11 g of protein per serving, it's leaner than many traditional ham products, but sodium is moderate at around 20 per cent of the daily value. Keep in mind, even lean ham varieties can add up in sodium, so limit servings to once per week or swap in turkey to stretch your intake.
5. Ziggy's Smoked Turkey Breast
Per 56 g (about three to four slices):
Calories: 47
Protein: 9 g
Fat: 0.6 g (Saturated: 0 g)
Sodium: 455 mg
Carbohydrates: 1.2 g (Sugars: 1.2 g)
Ziggy's, which is a Loblaw brand, makes a smoked turkey that is extra lean and decently high in protein. It would make a killer sandwich paired with veggies and honey mustard on high-fibre bread. But sodium is still an issue at 20 per cent of your daily recommended amount in a 56 g serving. Choose this for extra flavour once in a while, but for more frequent bites, substitute lower-sodium cooked turkey.
6. Lou's Kitchen Original Peameal Bacon
Per 56 g:
Calories: 59
Protein: 8 g
Fat: 2 g (Saturated: 0.66 g)
Sodium: 421mmg
Carbohydrates: 2 g (Sugars: 1 g)
Peameal bacon — what non-Canadians ironically call Canadian bacon — is a leaner alternative to traditional bacon, and Lou's version holds up relatively well. It's low in fat and calories, but sodium still climbs to nearly 30 per cent of the daily limit in a single serving, which is 85 g (two slices), according to the package. Stick closer to a 56 g serving, or go with a single slice to limit your sodium intake.
7. M&M Food Market Montreal Smoked Meat
Per 56 g (about two slices):
Calories: 61
Protein: 8 g
Fat: 3 g (Saturated: 1 g)
Sodium: 479 mg
Carbohydrates: 1 g
No Canadian deli meat list would be complete without Montreal-style smoked meat, used to make the classic sandwich on whole grain rye with mustard or paired with sauerkraut and Swiss cheese in a Reuben. M&M Food Market Montreal Smoked Meat gets high praise from customers for its tenderness and authentic flavour. Although it's not overly salty and less processed than salami and many cured meats, it's still moderately high in fat and sodium. It has a decent amount of protein from lean brisket, but its preparation means it's best positioned midway in the list as an occasional protein swap for sandwiches or charcuterie.
8. Piller's Extra-Lean Ham Kolbassa
Per 56 g:
Calories: 78
Protein: 10 g
Fat: 4 g (Saturated: 2 g)
Sodium: 493 mg
Carbohydrates: 0.6 g (Sugars: 0.6 g)
Traditional kolbassa can be pretty fatty, but this European-style lean ham version from Piller's is higher in protein with moderate fat. The sodium content is respectable for a ham product, but it nearly hits 20 per cent of the daily limit with just 493 g in a 56 g serving (the package serving suggestion is 100 g with 880 mg sodium). The ingredient list is traditional, though it includes nitrates. Try pairing a small portion with extra veggies to balance sodium intake.
9. San Daniele Smoked Prosciutto (Speck)
Per 56 g (about three to four slices):
Calories: 134
Protein: 16 g
Fat: 8 g (Saturated: 3 g)
Sodium: 986 mg
Carbohydrates: 1 g (Sugars: 0 g)
San Daniele is a brand owned by Ontario-based company Sofina Foods, which makes a range of authentic Italian charcuterie meats. This juniper-scented smoked prosciutto is rich in flavour, blending Italian salt-curing with Central European smoking. It's high in sodium, though — nearly 1,000 mg per 56 g serving — and moderately fatty. A little goes a long way, making it better suited to charcuterie boards in small portions (the package suggests 30 g) with fresh fruit, greens or whole grains to balance the saltiness.
10. Schneider's German Salami
Per 56 g (about 10 to 11 slices):
Calories: 224
Protein: 15 g
Fat: 17 g (Saturated: 6.5 g)
Sodium: 653 mg
Carbohydrates 1.9 g (Sugars: 0 g)
For a deli salami, this German-style option from Schneider's edges out other brands with its higher protein and slightly less sodium content than other brands. Still, it's high in fat and saturated fat, which places it near the bottom of the health rankings. Enjoy this one occasionally or pair it in small amounts (the suggested serving size is 30 g) with high-fiber, low-sodium ingredients like whole grain crackers or crisp vegetables.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Why LeMaitre (LMAT) Stock Is Trading Up Today
What Happened? Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) jumped 9.5% in the afternoon session after the company reported better-than-expected second-quarter financial results and raised its full-year outlook. The medical device maker reported second-quarter earnings per share of $0.60 on revenue of $64.2 million, which beat Wall Street's expectations. The company's sales jumped 15% from the previous year, pushed by higher prices and a 7% increase in the number of products sold. Strong international sales for its Artegraft product also contributed to the growth. Looking ahead, LeMaitre lifted its full-year 2025 revenue forecast to $251 million and increased its earnings guidance, signaling management's confidence in continued strong performance. Is now the time to buy LeMaitre? Access our full analysis report here, it's free. What Is The Market Telling Us LeMaitre's shares are not very volatile and have only had 8 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 26 days ago when the stock dropped 3% on the news that the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White House announced plans to impose a 35% tariff on Canadian imports, sparking renewed fears of a trade war. This news prompted a sell-off across major U.S. indexes, including the S&P 500 and the Dow Jones Industrial Average, as investors grew concerned about the potential economic impact of escalating protectionist policies. The healthcare sector is especially vulnerable to such tensions due to its deeply integrated supply chains with Canada for pharmaceuticals and medical devices, meaning increased costs and potential disruptions. Additionally, ongoing U.S. policy headwinds aimed at lowering drug prices and specific corporate challenges, like those faced by UnitedHealth Group, further compounded the sector's decline. As a result, the Health Care SPDR ETF (XLV) fell 1.0%, underperforming even as major indices pared some losses. LeMaitre is up 1% since the beginning of the year, but at $92.39 per share, it is still trading 14.4% below its 52-week high of $107.97 from November 2024. Investors who bought $1,000 worth of LeMaitre's shares 5 years ago would now be looking at an investment worth $3,164. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Associated Press
6 hours ago
- Associated Press
Imfinzi approved in Canada as first and only perioperative immunotherapy for muscle invasive bladder cancer
MISSISSAUGA, ON, Aug. 6, 2025 /CNW/ - Health Canada has granted a Notice of Compliance (NOC) for Imfinzi® (durvalumab) for the treatment of patients with resectable muscle invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by adjuvant Imfinzi monotherapy treatment after radical cystectomy. The approval is based on results from the NIAGARA Phase III trial, which were published in The New England Journal of Medicine.1,2 In a planned interim analysis, the Imfinzi-based perioperative regimen demonstrated a statistically significant and clinically meaningful 32% reduction in the risk of disease progression, recurrence, not undergoing surgery, or death versus neoadjuvant chemotherapy with radical cystectomy alone (based on event-free survival [EFS] hazard ratio [HR] of 0.68; 95% confidence interval [CI] 0.56-0.82; p<0.0001). Estimated median EFS was not yet reached for the Imfinzi plus gemcitabine and cisplatin arm versus 46.1 months for the comparator arm. An estimated 67.8% of patients treated with the regimen were event free at two years compared to 59.8% in the comparator arm.2 Results from the key secondary endpoint of overall survival (OS) showed that the Imfinzi-based perioperative regimen reduced the risk of death by 25% versus the comparator arm (based on OS HR of 0.75; 95% CI 0.59-0.93; p=0.011). Median survival was not yet reached for either arm. An estimated 82.2% of patients treated with the regimen were alive at two years compared to 75.2% in the comparator arm.2 Imfinzi was generally well tolerated, and no new safety signals were observed in the neoadjuvant and adjuvant settings. The most common adverse events (any Grade, occurring in ≥10% of patients) for the Imfinzi plus chemotherapy arm were nausea (53.6%), fatigue (51.5%), neutropenia (40.4%), anemia (38.7%), constipation (38.7%), decreased appetite (26.6%), rash (20.9%), pyrexia (20.8%), diarrhea (20.6%), abdominal pain (20.2%), vomiting (19.2%), blood creatine increased (18.5%), thrombocytopenia (17.2%), pruritus (15.1%), hypothyroidism (12.6%), neuropathy peripheral (12.5%), leukopenia (10.9%), and aspartate aminotransferase increased (10.4%).1 'Health Canada's approval of this durvalumab-based perioperative regimen represents a major advance for Canadians with muscle invasive bladder cancer, where nearly half will relapse despite curative treatment,' says Dr. Srikala Sridhar, Professor of Medicine at the University of Toronto, Genitourinary Medical Oncologist at the Princess Margaret Cancer Centre and NIAGARA trial investigator. 'Findings from the NIAGARA trial showed that this new regimen reduces risk of recurrence and significantly improves survival – which may offer new hope and potential to transform care in this setting.' 'The high rate of recurrence associated with muscle invasive bladder cancer is an ongoing challenge and source of concern for physicians and patients,' says Dr. Normand Blais, Medical Oncologist at the Centre hospitalier de l'Université de Montréal. 'The Health Canada approval based on results from the NIAGARA trial may now offer us the opportunity to increase the chance of better patient outcomes and long-term survival by the use of immunotherapy in this setting, which is very good news for patients and their families.' Bladder cancer is the 5th most common cancer in Canada, with more than 13,000 patients diagnosed each year.3 The most common type of bladder cancer is urothelial carcinoma, which begins in the urothelial cells of the urinary tract. Bladder cancer is considered muscle invasive when there is evidence of the tumour invading the muscle wall of the bladder but no distant metastases.4 In MIBC, approximately 50% of patients who undergo bladder removal surgery experience disease recurrence.5 Treatment options that prevent disease recurrence after surgery are critically needed in this curative-intent setting. 'This decision by Health Canada represents an important step forward for all Canadians affected by muscle invasive bladder cancer,' says Michelle Colero, Executive Director, Bladder Cancer Canada. 'For many patients and families, the fear of recurrence after surgery has been overwhelming. This new treatment option may offer renewed hope for longer, healthier lives.' About NIAGARA2 NIAGARA is a randomized, open-label, multi-centre, global Phase III trial evaluating perioperative Imfinzi as treatment for patients with MIBC before and after radical cystectomy. In the trial, 1,063 patients were randomized to receive four cycles of Imfinzi plus neoadjuvant chemotherapy prior to cystectomy followed by eight cycles of Imfinzi monotherapy, or neoadjuvant chemotherapy alone prior to cystectomy with no further treatment after surgery. NIAGARA is the largest global Phase III trial in this setting to date. The trial is being conducted at 192 centres in 22 countries across North America (including Canada), South America, Europe, Australia and Asia. Its dual primary endpoints are EFS and pathologic complete response at the time of cystectomy. Key secondary endpoints are OS and safety. About Imfinzi Imfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80 proteins, countering the tumour's immune-evading tactics and releasing the inhibition of immune responses. About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical business whose innovative medicines are used by millions of patients worldwide. The company's core areas of scientific focus are Oncology; Cardiovascular, Renal and Metabolic (CVRM); Rare Disease; Respiratory & Immunology; and Vaccine & Immune Therapies. In Canada, the company employs more than 2,400 people and recently announced a major expansion of its research footprint in Mississauga – including the expansion of its AstraZeneca R&D Hub and the creation of a new Alexion Development Hub for Rare Diseases. AstraZeneca was recently recognized as one of Canada's Top 100 Employers, one of Canada's Most Admired Corporate Cultures, and a Greater Toronto Top Employer. AstraZeneca is committed to contributing to a more sustainable future for people, society and planet taking important steps to help tackle some of the most pressing sustainability challenges globally – from climate and biodiversity loss, to health equity and health system resilience. AstraZeneca was one of the first seven companies globally to have its net zero targets verified by the Science-Based Targets initiative (SBTi) Corporate Net-Zero Standard. For more information, please visit the company's website at Imfinzi® and the AstraZeneca logo are registered trademarks of AstraZeneca AB, used under license by AstraZeneca Canada Inc. References: SOURCE AstraZeneca Canada Inc.


Axios
7 hours ago
- Axios
Breaking down Chicago's "worst in the world" air quality
Chicago had the distinction last week of having the worst air quality in the world due to Canadian wildfires. The big question: How could Chicago have worse air quality than Canada or states closer to the fires? How it works: In a high-pressure dome, as Chicago had last week, the air gradually descends. If the plume of smoke is 5-10,000 feet above the ground, for example, the air carrying the smoke starts to descend toward us, National Weather Service meteorologist Todd Kluber told Axios. The air is moving clockwise from the Northwest, through Canada and into the Great Lakes, putting Chicago smack in the middle of the wind's path. Reality check: The air quality was terrible here, but it could just be that more sensors were monitoring the air in Chicago than where the fires were happening, Kluber said. Another big question: Who is the least vulnerable age group for poor air quality and why? How it works: Poor air quality warnings generally target young children, teens and seniors because "people's lungs keep growing until age about 20-25, so anything in those critical years that can harm and stunt lung development can create problems in a person's later years as there is a long tail of lung capacity decline after that point," Respiratory Health Association's Brian Urbaszewski told Axios. Plus: Children tend to breathe about 50% more air per pound of body weight than adults, the EPA notes.